Federal Advocacy Efforts
Learn more about policy proposals at the national level that may impact access to reproductive health services, including abortion care, for high-risk individuals.
SMFM joined more than 100 organizations on a letter to Congressional leaders asking for increased funding to modernize the nation’s public health data systems.
SMFM joined nearly 90 organizations in a letter calling for increased funding for international family planning and reproductive health programs in FY 2023.
SMFM joined other national medical societies in a letter to U.S. Senators in our support of the Women’s Health Protection Act and urging them for their support of this critical legislation.
SMFM joined over 100 reproductive health, rights, and justice organizations in a letter to President Biden requesting him to address the abortion crisis in our country during his upcoming State of the Union address to the nation.
SMFM joined a letter with other reproductive health, rights and justice organizations on the 48th anniversary of the Helms Amendment requesting President Biden to remove the Helms Amendment from the upcoming FY23 President’s Budget and support the Abortion is Health Care Everywhere Act.
SMFM joined 55 organizations in sending a letter to the U.S. Office of Management and Budget to request substantial federal funding for the Title X Family Planning Program in the FY23 Presidential Budget.
SMFM joined other medical and health care organizations in sending a letter to President Biden and Vice President Harris to lift the in-person dispensing requirement for mifepristone during the COVID-19 pandemic.
SMFM joined 100 organizations in sending a letter to President-Elect Biden urging him to rescind the human fetal tissue research restrictions that were imposed in 2019.
SMFM joined nearly 100 organizations in sending a letter to the NIH Human Fetal Tissue Ethics Advisory Board expressing support for the continued use of human fetal tissue in biomedical research.
SMFM and ACOG wrote to the FDA urging them to expand its recent policy to apply to the REMS and Elements to Assure Safe Use requirements for certain drugs requiring in-person dispensation, especially mifepristone.
SMFM joins ACOG, March of Dimes, AMCHP and the Preeclampsia Foundation in a letter to the House Energy and Commerce Committee expressing strong support for the Maternal Health Quality Improvement Act (H.R. 4995) and the Helping Medicaid Offer Maternity Services Act.
SMFM joined universities and other research-minded organizations to write to Sec. Azar in strong opposition to the new policies on research using human fetal tissue announced by the Department of Health and Human Services.
SMFM joins with other national health professional organizations to write to Congressional appropriators, urging them to include language in the FY 2020 Labor, Health and Human Services, and Education (LHHS) Appropriations bill to support the Title X Family Planning program and ensure that no funds are used to implement the Administration’s final rule.
